Skip to content

Johnson & Johnson

US · JNJ #25 by market cap Listed 1970
285.75 +2.23 +0.79%
Periodic snapshot; not a real-time feed. · 2026-11-13 20:01

Price chart

Pre-market 285.00 +0.52%
After-hours 286.67 +0.32%
Overnight 283.78 +0.09%
285.75221.80285.752026-05-182026-11-13
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on JNJ?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +29.6% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 0.7% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bullish
  • Price is above its 20-day average and above its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → B

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2855 U.S. stocks StockVane covers.

Last computed: 2026-11-14 20:27 UTC

Data coverage: 6 of 6 factors. Missing data is not a zero score.

Overall B
ValuationGrowthProfitMomentumHealthAnalyst
Valuation D-

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 43.4x Better than 14%
Forward P/E 27.4x Better than 23%
Price / Sales 6.6x Better than 17%
P/E vs own 5-yr range 100th pctl Better than 1%
Growth B

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 5.6% Better than 49%
Net income CAGR (3Y) 14.3% Better than 65%
Free cash flow CAGR (3Y) 4.0% Better than 43%
Profitability A+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 67.9% Better than 81%
Operating margin 27.2% Better than 87%
Net margin 28.5% Better than 88%
Return on equity 35.0% Better than 90%
Return on invested capital 22.5% Better than 92%
Momentum A

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 10.3% Better than 84%
6-month return 27.4% Better than 82%
12-month return (ex latest month) 32.2% Better than 73%
Distance below 52-week high 0.8% Better than 98%
Financial Health C+

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.0x Better than 20%
Debt to assets 24.1% Better than 50%
Interest coverage 34.6x Better than 88%
Free cash flow / net income 72.1% Better than 22%
Analyst View C-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 68.8% Better than 47%
Upside to average target 1.4% Better than 12%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W +3.45%
1M +14.94%
3M +9.57%
6M +25.34%
YTD +40.30%
1Y +49.65%
3Y +110.78%
5Y +99.12%

Key statistics

Price & volume

Prev close
283.52
Open
285.00
Day range
281.68 - 288.11
Avg price
286.08
Volume
6.29M
Turnover
1.80B
Amplitude
2.27%
52-week range
191.58 - 288.11

Valuation

P/E
25.91
P/E (TTM)
43.43
P/B
8.44
EPS
11.03
Net profit
26.55B
Net assets
81.53B

Share structure

Market cap
687.89B
Float cap
687.50B
Shares out
2.41B

Dividend & listing

Dividend (TTM)
5.28
Listing date
1970-01-01
52-week range 98% of range
191.58 288.11

0.8% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-394.95M net over the window

Short interest

Shares short
16.77M
As of
2026-10-15

Frequently asked questions

What is the current stock price of Johnson & Johnson (JNJ)?

Johnson & Johnson last traded at 285.75. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Johnson & Johnson's market cap?

About 687.89B.

What is the P/E ratio of Johnson & Johnson?

The trailing twelve-month P/E is 43.43, above its own 5-year average of 22.20 — toward the top of its historical range (99.92% percentile). See the Valuation tab for the full history.

Does Johnson & Johnson pay a dividend?

Yes. The trailing dividend yield is 1.85%. The 2025 payout was up 4.7% from 2024. See the Dividends tab for the full payment history.

Is Johnson & Johnson a buy according to analysts?

The consensus of 16 analysts is a Buy rating, with an average 12-month price target of 289.73, which implies 1.4% upside from the current price. This is not investment advice.

What is Johnson & Johnson's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Johnson & Johnson a B (Buy). Twelve-month momentum in the top 15% of the universe, above its 200-day average. Not investment advice.

Quote time 2026-11-13 20:01:17 · For reference only, not investment advice and not tailored to your situation.

Johnson & Johnson discussion 1 comments

  1. talc litigation headlines still spook this stock every few months but the pharma pipeline keeps quietly delivering. slow and steady, exactly how I like my healthcare names.

Add a comment